Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HDAC inhibitors and immunotherapy; a double edged sword?

31 Jul 2014

Abstract excerpt

// Michiel Kroesen 1,2 , Paul R. Gielen 1,* , Ingrid C. Brok 1,* , Inna Armandari 1 , Peter M. Hoogerbrugge 2,3 and Gosse J. Adema 1 1 Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands 2 Department of Pediatric Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands 3 Princes Máxima Center for Pediatric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone Deacetylase Inhibitors Research
Share to Peptidase Inhibition and Analysis
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25115382
DOI: 10.18632/oncotarget.2289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HDAC inhibitors and immunotherapy; a double edged sword?PMID 25115382Read ↗

Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulationSemantic proximity Read ↗

Histone Deacetylase Inhibitors as Immunomodulators in Cancer TherapeuticsSemantic proximity Read ↗

HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesSemantic proximity Read ↗

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification InhibitorsSemantic proximity Read ↗

Epigenetic Modulation with Histone Deacetylase Inhibitors in Combination with ImmunotherapySemantic proximity Read ↗

Mechanisms of HDACs in cancer developmentSemantic proximity Read ↗

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer ImmunotherapySemantic proximity Read ↗

Targeting histone deacetylases for the treatment of cancer and inflammatory diseasesSemantic proximity Read ↗

HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseasesSemantic proximity Read ↗

Targeting Histone Deacetylases: Opportunities for Cancer Treatment and ChemopreventionSemantic proximity Read ↗

Histone deacetylase inhibitors: a patent review (2009 – 2011)Semantic proximity Read ↗

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.